Overexpression of EZH2 in Multiple Myeloma Is Associated with Poor Prognosis Regardless of Treatment with Novel Agents or High-Dose Chemotherapy

被引：0
|
作者：
Schroeder, Mark A.
Fiala, Mark A.
Ghobadi, Armin
Stockerl-Goldstein, Keith E.
Wildes, Tanya M.
Vij, Ravi
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4335
引用
收藏
页数：2
相关论文
共 50 条
  • [41] High-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma and the role of novel agents: A single centre experience
    Fenk, R.
    Neubauer, F.
    Bruns, I.
    Schroeder, T.
    Saure, C.
    Kondakci, M.
    Haas, R.
    Kobbe, G.
    ONKOLOGIE, 2010, 33 : 245 - 245
  • [42] Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation
    Inamoto, Yoshihiro
    Kurahashi, Shingo
    Imahashi, Nobuhiko
    Fukushima, Nobuaki
    Adachi, Tatsuya
    Kinoshita, Tomohiro
    Tsushita, Keitaro
    Miyamura, Koichi
    Naoe, Tomoki
    Sugiura, Isamu
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (05) : 283 - 286
  • [43] Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation
    Inamoto, Y.
    Kurahashi, S.
    Fukushima, N.
    Imahashi, N.
    Murata, M.
    Tsushita, K.
    Miyamura, K.
    Kinoshita, T.
    Naoe, T.
    Kodera, Y.
    Sugiura, I.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S182 - S182
  • [44] Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma
    Liu, Dong-Cai
    Yang, Zhu-Lin
    PATHOLOGY RESEARCH AND PRACTICE, 2011, 207 (08) : 472 - 478
  • [45] High-dose therapy and innovative approaches to treatment of multiple myeloma
    Barlogie, B
    SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 21 - 27
  • [46] Cost-effectiveness of high-dose chemotherapy in first-line treatment of advanced multiple myeloma
    Sampson, FC
    Beard, SM
    Scott, F
    Vandenberghe, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) : 1015 - 1019
  • [47] The role of high-dose chemotherapy followed by peripheral blood stem cell transplantation for the treatment of multiple myeloma
    Siddiqui, Mustaqeem
    Gertz, Morie
    LEUKEMIA & LYMPHOMA, 2008, 49 (08) : 1436 - 1451
  • [48] High-dose chemotherapy with treosulfan and melphalan before autologous transplantation in multiple myeloma
    Gillich, C.
    Jeker, B.
    Aebi, Y.
    Largiader, C.
    Hayoz, M.
    Taleghani, B. Mansouri
    Bacher, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2021, 151 : 21 - 21
  • [49] High-dose chemotherapy with autologous stem-cell support in multiple myeloma
    Ruckser, R
    Kier, P
    Buxhofer, V
    Kittl, E
    Tatzreiter, G
    Vedovelli, H
    Zelenka, P
    Hübl, G
    Hinterberger, W
    ACTA MEDICA AUSTRIACA, 2000, 27 : 40 - 42
  • [50] High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
    Child, JA
    Morgan, GJ
    Davies, FE
    Owen, RG
    Bell, SE
    Hawkins, K
    Brown, J
    Drayson, MT
    Selby, PJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19): : 1875 - 1883
12345